[Nephropathy caused by radiocontrast media].
The paper contains the overview of the definition, clinical features, pathomechanism and the risk factors of the radiocontrast-induced nephropathy. Authors reviewed the methods of prevention and treatment of the renal failure induced by radiocontrast media with the special attendance to the results of the latest clinical trials.
Kolarz
Marek
M
Stacja Dializ Miechów Niepubliczny, Zakład Opieki Zdrowotnej. mkol@mp.pl
Sułowicz
Władysław
W
D000111:Acetylcysteine / Q000627:therapeutic use; D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000009:adverse effects*; D018818:Fenoldopam / Q000627:therapeutic use; D005440:Fluid Therapy; D017583:Hemodiafiltration; D006440:Hemofiltration; D006801:Humans; D007552:Isotonic Solutions / Q000627:therapeutic use; D007684:Kidney Tubules / Q000187:drug effects; D019275:Radiopharmaceuticals / Q000009:adverse effects
D003287:Contrast Media; D007552:Isotonic Solutions; D019275:Radiopharmaceuticals; D018818:Fenoldopam; D000111:Acetylcysteine